- Exchange: -
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Fresenius SE & Co KGaA
FRE3:GY
Ticker Delisted
Snapshot for Fresenius SE & Co KGaA (FRE3)
| Open: | - | Day's Range: | - | Volume: | 0 | Bid: | - |
|---|---|---|---|---|---|---|---|
| Previous Close: | - | 52wk Range: | - | 1-Yr Rtn: | - | Ask: | - |
Key Statistics for FRE3
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | 11.9164 |
| Earnings Per Share (EUR) (ttm) | 4.8600 |
| Est. EPS (EUR) (12/2012) | 5.3330 |
| Est. PEG Ratio | 0.8097 |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 80.66 |
| Enterprise Value (M EUR) (ttm) | - |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/01/2012 |
More FRE3 Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for FRE3
- Operating
- Investing
- Financing (M/EUR)
Company Profile & Key Executives for FRE3
Fresenius SE & Co KGaA i s a global health care group with products and services for dialysis, the hospital and the medical care of patients at home. The Company sells dialysis, infusion, transfusion, and diagnostics equipment and systems, blood separators and plasma and hemofilters, nutritional liquids, and solid and liquid pharmaceuticals.
| Ulf Mark SchneiderChairman-Mgmt Board | Stephan SturmCFO/Member-Mgmt Board |
| Juergen GoetzChief Legal & Compliance Ofcr | Rainer BauleMember-Mgmt Board |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page